What Is Letrozole 5 mg?
Letrozole 5 mg refers to a 5 mg strength of letrozole, a nonsteroidal aromatase inhibitor that reduces estrogen production.
Letrozole is primarily used as hormonal therapy for certain types of breast cancer in postmenopausal women.
Some breast cancers depend on estrogen to grow.
These are known as hormone receptor-positive breast cancers.
Estrogen can stimulate the growth and survival of cancer cells that express estrogen receptors.
Letrozole works by inhibiting aromatase, an enzyme involved in estrogen production.
In postmenopausal women, a significant proportion of estrogen is produced through the conversion of androgens into estrogens in peripheral tissues.
By blocking aromatase, letrozole reduces circulating estrogen levels.
This can slow the growth of estrogen-dependent breast cancer cells.
Letrozole is also used off-label for ovulation induction in selected patients experiencing infertility associated with ovulatory dysfunction, including some patients with polycystic ovary syndrome (PCOS).
In fertility treatment, temporary suppression of estrogen production can stimulate hormonal signals that support ovarian follicle development.
However, oncology treatment and fertility treatment involve different treatment objectives, doses and schedules.
Important: Letrozole is not a general fertility supplement, estrogen replacement medicine or guaranteed treatment for infertility.
How Does Letrozole 5 mg Work?
1. Inhibits the Aromatase Enzyme
Letrozole selectively inhibits aromatase, an enzyme responsible for converting androgens into estrogens.
2. Reduces Estrogen Production
By inhibiting aromatase, letrozole decreases estrogen synthesis.
3. Suppresses Estrogen-Dependent Tumor Signaling
Reduced estrogen availability can decrease stimulation of hormone receptor-positive breast cancer cells.
4. Helps Slow Cancer Cell Proliferation
In appropriate patients, estrogen suppression can slow the growth of hormone-sensitive breast cancer.
5. Supports Adjuvant Breast Cancer Treatment
Letrozole may reduce the risk of recurrence when prescribed for eligible patients after primary breast cancer treatment.
6. Provides Endocrine Therapy for Advanced Breast Cancer
Letrozole may help control certain advanced or metastatic hormone receptor-positive breast cancers.
7. Alters Hormonal Feedback During Fertility Treatment
Temporary estrogen suppression can increase follicle-stimulating hormone signaling in selected patients.
8. Supports Ovulation Induction
When prescribed for appropriate patients, letrozole may stimulate ovarian follicle development and ovulation.
Important: The clinical effects of letrozole depend on the indication, hormonal status, dose and treatment schedule.
Uses of Letrozole 5 mg
1. Hormone Receptor-Positive Early Breast Cancer
Letrozole is approved for adjuvant treatment of certain postmenopausal women with hormone receptor-positive early breast cancer.
2. Extended Adjuvant Breast Cancer Therapy
Letrozole may be used after completion of an appropriate course of tamoxifen therapy in eligible postmenopausal patients.
3. Advanced Breast Cancer
Letrozole may be prescribed for selected postmenopausal patients with hormone receptor-positive or hormone receptor-unknown advanced breast cancer, according to the applicable product label.
4. Metastatic Hormone Receptor-Positive Breast Cancer
Letrozole may be used alone or as part of an appropriate combination regimen for selected patients with metastatic breast cancer.
5. Estrogen-Dependent Tumor Growth Suppression
Letrozole reduces estrogen production, helping limit hormonal stimulation of susceptible tumors.
6. Ovulation Induction
Letrozole is used off-label in some countries to induce ovulation in selected patients with anovulatory infertility.
7. PCOS-Related Anovulatory Infertility
Letrozole is recommended as a first-line pharmacological ovulation induction option for many women with PCOS-related anovulatory infertility when other infertility factors have been appropriately assessed.
8. Selected Fertility Treatment Protocols
Fertility specialists may prescribe letrozole as part of individualized ovulation induction or ovarian stimulation protocols.
Important: A 5 mg daily fertility regimen does not establish that a specific 5 mg tablet product is approved or available. Breast cancer treatment generally uses a different dosing schedule.
How to Take Letrozole Tablets
Letrozole should be taken only according to the prescribing specialist’s instructions.
General Administration Instructions
- Confirm the prescribed strength and indication.
- Take the medicine exactly as directed.
- Swallow the tablet with water.
- Letrozole can generally be taken with or without food.
- For daily oncology treatment, take it at approximately the same time each day.
- Do not increase or decrease the dose independently.
- Do not use fertility treatment schedules for breast cancer treatment.
- Attend scheduled clinical appointments.
- Report significant adverse effects promptly.
- Do not take letrozole during pregnancy.
Dosage Information
| Indication | General Dosage Guidance |
|---|---|
| Early Breast Cancer | Standard Labeled Dose: 2.5 mg Once Daily |
| Extended Adjuvant Therapy | Standard Labeled Dose: 2.5 mg Once Daily |
| Advanced Breast Cancer | Standard Labeled Dose: 2.5 mg Once Daily |
| Ovulation Induction | Commonly Studied Regimens Include 2.5–7.5 mg Daily for 5 Days, Under Specialist Supervision |
| PCOS-Related Infertility | Dose and Cycle Days Determined by Fertility Specialist |
| Severe Hepatic Impairment | May Require Dose Adjustment According to Product Label |
| Treatment Duration | Depends on Indication and Clinical Response |
Important: The standard oncology dose is 2.5 mg daily. Do not substitute a 5 mg tablet for the prescribed oncology dose.
Fertility treatment requires cycle-specific instructions, assessment of pregnancy status and appropriate monitoring.
Can Letrozole Be Taken With Food?
Yes. Letrozole can generally be taken with or without food.
Can Letrozole Be Used Daily?
For breast cancer, letrozole is generally prescribed daily.
For fertility treatment, it is usually prescribed for a limited number of days within a menstrual cycle.
What If a Dose Is Missed?
Follow the prescribing instructions.
For daily treatment, take a missed dose when remembered unless it is nearly time for the next dose.
Do not double the dose.
For fertility treatment, contact the prescribing clinic because timing within the cycle matters.
What If Too Much Letrozole Is Taken?
Seek medical advice promptly.
Do not take additional tablets to compensate for missed doses.
How Long Does Letrozole Take to Work?
The time required for clinical benefit depends on the indication.
Breast Cancer Treatment
Estrogen suppression begins after treatment starts, but clinical benefit is evaluated over time.
Adjuvant Therapy
Letrozole is used over an extended period to reduce the risk of cancer recurrence in eligible patients.
Advanced Breast Cancer
Treatment response may be assessed through clinical examination, imaging and other appropriate investigations.
Ovulation Induction
The medicine is generally taken for a short course early in the menstrual cycle, followed by monitoring for follicle development and ovulation.
Important: Letrozole does not guarantee tumor response, ovulation or pregnancy.
Common Side Effects
Possible side effects include:
- Hot Flashes
- Joint Pain
- Muscle Pain
- Fatigue
- Headache
- Dizziness
- Nausea
- Increased Sweating
- Weakness
- Sleep Disturbances
- Bone Pain
- Back Pain
- Hair Thinning
- Peripheral Swelling
- Increased Cholesterol
- Vaginal Dryness
- Mood Changes
Side effects may vary according to the indication, dose and treatment duration.
Serious Side Effects
Seek medical attention if any of the following occur:
- Severe allergic reactions
- Chest pain
- Sudden shortness of breath
- Stroke-like symptoms
- Severe or persistent bone pain
- Suspected fractures
- Significant visual disturbances
- Severe dizziness or fainting
- Serious skin reactions
- Symptoms of significant liver dysfunction
Important Serious Risks
1. Bone Mineral Density Reduction
Long-term estrogen suppression may reduce bone mineral density and increase fracture risk.
2. Osteoporosis
Patients receiving prolonged letrozole treatment may require bone health assessment.
3. Cardiovascular Events
Certain cardiovascular events have been reported during aromatase inhibitor treatment.
4. Increased Cholesterol
Letrozole may increase serum cholesterol levels.
5. Severe Musculoskeletal Symptoms
Some patients experience significant joint pain, muscle pain or stiffness.
6. Liver Function Abnormalities
Liver enzyme elevations and rare clinically significant liver injury may occur.
7. Embryo-Fetal Toxicity
Letrozole can harm a developing fetus and must not be used during pregnancy.
8. Severe Hypersensitivity Reactions
Serious allergic reactions require immediate medical assessment.
Contraindications & Precautions
1. Pregnancy
Letrozole can cause fetal harm and must not be taken during pregnancy.
2. Pregnancy Testing
Patients who can become pregnant should undergo appropriate pregnancy assessment before treatment.
3. Breastfeeding
Breastfeeding is not recommended during treatment and for three weeks after the final dose under U.S. labeling.
4. Contraception
Patients who can become pregnant should use effective contraception during treatment and for three weeks after the final dose, except when following a specifically supervised fertility protocol.
5. Bone Health
Long-term treatment may reduce bone mineral density.
6. Osteoporosis
Patients with osteoporosis or fracture risk factors may require bone health monitoring.
7. Cardiovascular Disease
Patients with cardiovascular risk factors should inform their healthcare professional.
8. Hypercholesterolemia
Cholesterol monitoring may be appropriate during prolonged treatment.
9. Liver Impairment
Severe liver impairment may require dose modification.
10. Kidney Impairment
Patients with significant kidney disease should inform their healthcare professional.
11. Premenopausal Hormonal Status
Letrozole is generally used for breast cancer in postmenopausal patients unless an oncology specialist prescribes it as part of an appropriate ovarian suppression regimen.
12. Fertility Treatment Monitoring
Patients undergoing ovulation induction may require ultrasound monitoring and other fertility assessments.
13. Multiple Pregnancy Risk
Ovulation induction may increase the likelihood of multiple pregnancy compared with spontaneous conception.
14. Ovarian Response
Excessive ovarian response or other fertility-related complications require specialist assessment.
15. Drug Interactions
Patients should inform their healthcare professional about all prescription medicines, supplements and hormonal therapies.
Estrogen-containing medicines may counteract the estrogen-lowering effects of letrozole.
Tamoxifen may reduce letrozole exposure and is not routinely administered concurrently.
16. Dizziness and Fatigue
Patients experiencing dizziness or fatigue should avoid driving or operating machinery until they know how the medicine affects them.
17. Long-Term Treatment
Patients receiving prolonged oncology therapy require regular assessment of treatment effectiveness and adverse effects.
18. Medical Monitoring
Healthcare professionals may monitor:
- Treatment Response
- Cancer Recurrence Risk
- Bone Mineral Density
- Fracture Risk
- Cholesterol Levels
- Joint Pain
- Muscle Pain
- Liver Function When Indicated
- Kidney Function When Indicated
- Cardiovascular Risk
- Fatigue
- Dizziness
- Menopausal Symptoms
- Medication Interactions
- Treatment Adherence
- Pregnancy Status When Relevant
- Follicular Development During Fertility Treatment
- Ovulation Response
- Overall Clinical Condition
Potential Therapeutic Advantages
- Nonsteroidal Aromatase Inhibitor.
- Estrogen Production Suppression.
- Hormone Receptor-Positive Breast Cancer Treatment.
- Early Breast Cancer Adjuvant Therapy.
- Extended Adjuvant Breast Cancer Therapy.
- Advanced Breast Cancer Management.
- Metastatic Breast Cancer Treatment.
- Targeted Endocrine Therapy.
- Oral Tablet Administration.
- Established Aromatase Inhibition.
- Ovulation Induction in Selected Patients.
- PCOS-Related Anovulatory Infertility Management.
- Individualized Fertility Treatment.
- Specialist-Supervised Hormonal Therapy.
Disadvantages / Limitations
- Risk of Bone Mineral Density Reduction.
- Osteoporosis Risk.
- Joint Pain.
- Muscle Pain.
- Hot Flashes.
- Fatigue.
- Dizziness.
- Headache.
- Increased Cholesterol.
- Potential Cardiovascular Complications.
- Pregnancy Contraindication.
- Possible Liver Function Abnormalities.
- Requires Medical Monitoring.
- Fertility Use May Be Off-Label.
- Not Suitable for Every Breast Cancer Type.
- Does Not Guarantee Ovulation.
- Does Not Guarantee Pregnancy.
- Does Not Guarantee Cancer Cure.
Important Notes
Generic Name: Letrozole.
Requested Strength: 5 mg.
Common Commercial Strength: 2.5 mg.
Drug Class: Nonsteroidal Aromatase Inhibitor.
Therapeutic Category: Hormonal Anticancer Therapy.
Primary Approved Use: Selected Hormone Receptor-Positive Breast Cancer.
Additional Clinical Use: Ovulation Induction Under Specialist Supervision.
Mechanism of Action: Aromatase Inhibition.
Route: Oral.
Standard Oncology Dose: 2.5 mg Once Daily.
Fertility Dose: Individualized.
Pregnancy: Contraindicated.
Bone Health Monitoring: Important During Long-Term Treatment.
Medical Supervision: Required.
Storage: Follow Original Product Labeling.
Frequently Asked Questions
1. What is Letrozole 5 mg used for?
Letrozole is used for certain hormone receptor-positive breast cancers and is also prescribed off-label for ovulation induction in selected patients. The exact 5 mg product strength must be verified.
2. Is Letrozole a chemotherapy medicine?
Letrozole is an endocrine or hormonal anticancer medicine, not conventional cytotoxic chemotherapy.
3. How does Letrozole work?
It inhibits aromatase, reducing estrogen production.
4. Is Letrozole used for breast cancer?
Yes. It is approved for selected breast cancer indications, primarily in postmenopausal women.
5. Is Letrozole used for infertility?
Yes. It is prescribed off-label for ovulation induction in selected patients.
6. Is Letrozole used for PCOS?
Yes. Letrozole is commonly used for ovulation induction in patients with PCOS-related anovulatory infertility.
7. Is Letrozole 5 mg a standard breast cancer dose?
No. The standard labeled breast cancer dose is generally 2.5 mg once daily.
8. Can Letrozole help with ovulation?
Yes. It can stimulate ovulation in selected patients with ovulatory dysfunction.































































